02309nas a2200121 4500000000100000008004100001260001200042100004100054245003300095856008300128300000800211520196800219 2023 d c12/20231 aGlobal Partnership for Zero Leprosy 00aGPZL: New Strategy 2024-2026 uhttps://zeroleprosy.org/wp-content/uploads/2024/01/GPZL-strategy-2024-2026.pdf a1-63 a
The Global Partnership for Zero Leprosy (GPZL) is a coalition committed to ending leprosy, also known as Hansen’s disease. GPZL convenes stakeholders, links expertise, and empowers and leverages the collective strengths of our members towards the ultimate goal of zero leprosy: zero infection and disease, zero disability, zero stigma and discrimination.
For the period 2024-2026, without losing the wider long-term vision of zero leprosy, the GPZL Leadership Team has chosen to focus primarily on objectives related to zero transmission of leprosy. It believes that this focus is warranted considering the current momentum, within WHO and at country level, towards interruption of transmission.
The headline objectives and strategies for 2024-2026 are:
a) Facilitate the implementation and scaling-up of existing and new tools to interrupt transmission, by:
b) Align and accelerate research with a focus on zero transmission, by:
c) Prioritise people and their rights in our zero leprosy efforts, by: